Human interferon-beta formulations
The invention provides a stable pharmaceutical composition containing biologically active human interferon- (IFN- ), preferably IFN 1 b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides s...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention provides a stable pharmaceutical composition containing biologically active human interferon- (IFN- ), preferably IFN
1
b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides stable IFN- lyophilizates prepared from biologically active IFN- , dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. |
|---|